Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.

Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing. - 2020

Aims: Identify the attitudes and interests of primary care providers (PCPs) in applying clinical pharmacogenomics (PGx) test results. Materials & methods: A questionnaire was designed and then disseminated to PCPs across the MedStar Health System. Results: Ninety of 312 (29%) PCPs responded and were included in analyses. Seventy-six (84%) had heard of PGx and 12 (13%) previously ordered PGx testing. Most, 68 (76%), believed PGx can improve care; however, a minority, 23 (26%), reported confidence in using PGx in prescribing decisions. Sixty-four (70%) wanted a pharmacist consultation. PCPs desired PGx for antidepressants (75%), proton pump inhibitors (72%) and other medications. Conclusion: Most PCPs felt unprepared to interpret PGx results and desired pharmacist consultations. These data can inform future PGx implementations with PCPs.


English

1462-2416

10.2217/pgs-2020-0064 [doi]


*Attitude of Health Personnel
*Health Personnel/px [Psychology]
*Pharmacogenomic Testing/mt [Methods]
*Primary Health Care/mt [Methods]
*Surveys and Questionnaires
Female
Humans
Male
Nurse Practitioners/px [Psychology]
Pharmacogenetics/mt [Methods]
Physician Assistants/px [Psychology]
Physicians, Primary Care/px [Psychology]
Precision Medicine/px [Psychology]


MedStar Medical Group


Assistant Vice President
Associate Dean for Research Development
MedStar Center for Successful Aging
MedStar Health
Pharmacogenomics
Vice President


Journal Article

Powered by Koha